quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·10d
PRRelease
Pacira BioSciences Inc. logo

Pacira Presents Real-World Data on EXPAREL® Showing Lower Total Healthcare Costs in Outpatient Total Hip and Knee Arthroplasty Procedures

PCRX· Pacira BioSciences Inc.
Health Care
Original source

Companies

  • PCRX
    Pacira BioSciences Inc.
    Health Care

Recent analyst ratings

  • Dec 9UpdateBarclays$27.00
  • Nov 17UpdateH.C. Wainwright-
  • Jul 25UpdateTruist$30.00
  • Jan 30UpdateTruist$25.00
  • Aug 13UpdateTruist$8.00
  • Aug 12UpdatePiper Sandler$11.00

Related

  • INSIDER1d
    SEC Form 4 filed by Cross Shawn
  • SEC6d
    SEC Form PREC14A filed by Pacira BioSciences Inc.
  • PR7d
    Pacira to Report First Quarter 2026 Financial Results on Thursday April 30, 2026
  • SEC14d
    SEC Form SCHEDULE 13G filed by Pacira BioSciences Inc.
  • PR15d
    Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
  • PR24d
    Pacira BioSciences to Present Real-World Data on EXPAREL® Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Pacira BioSciences Inc.
  • INSIDER35d
    Amendment: SEC Form 4 filed by Kronenfeld Mark A.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022